SESSION II: TRANSLATIONAL PATHWAY FOR TRANSCATHETER AORTIC VALVE
SESSION III: TRANSLATIONAL PATHWAY FOR TRANSCATHETER MITRAL/TRICUSPID VALVE DEVICES
2 of 5

The TAVR Development from First in Man to Phase 3 and Beyond

Martin Leon, MD

Professor of Medicine at Columbia University Medical Center

Learning Objectives

  • Learn the steps for generating clinical evidence that leads to device approval
  • Learn the importance of collaboration with other’s expertise and specialty
  • Understand the importance of standardized endpoints
  • Learn the TAVR outcome and impact on survival
  • Learn the steps for expanding the clinical indication for TAVR